Abstract
Silver staining profiles of Pick bodies (PBs) and their relation to tau-like immunoreactivity were examined on hippocampal sections and compared with those of neurofibrillary tangles of Alzheimer type (NFTs). Pairs of mirror sections were double-fluorolabeled with an anti-paired helical filament tau (AT8) antibody and thiazin red (TR), a fluorochrome that identifies fibrillary structures such as NFTs. One of the paired sections was subsequently stained using the Gallyas method (GAL), and the other using the Campbell-Switzer method (CS). By comparison of the same microscopic field on fluorolabeled sections and on both silver-stained paired sections, four different profiles of each structure could be distinguished: AT8 immunoreactivity, affinity to TR, argyrophilia with GAL or CS staining. PBs, containing mainly three-repeat (3R) tau, were positive for CS but not for GAL and its affinity to TR was, at most, weak. This selective affinity of PBs to CS is in sharp contrast with tau-positive structures of corticobasal degeneration/progressive supranuclear palsy, which are positive for GAL but not for CS, as we reported previously. This contrast is explainable if the argyrophilia with CS is related to deposits containing 3R tau, while that with GAL is linked to those containing four-repeat (4R) tau. Indeed, NFTs, containing both 3R and 4R tau, are positive for both CS and GAL, as expected. Taken together, differences in molecular composition of tau protein in these deposits are linked to their argyrophilic properties that are dependent on the staining method. Although explanations for these empirical differences are not yet available, awareness of this clear distinction is potentially of diagnostic and pathological relevance.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Degenerative tauopathies are characterized by tau-positive deposits, and some of them are considered to be diagnostic hallmarks for some clinicopathological entities. Tauopathies are currently classified according to the difference in their molecular species [three-repeat (3R) or four-repeat (4R)] of pathologically phosphorylated tau [26]. Disease-specific definition of tau-positive deposits, however, is still a challenge because differentiation based on the their immunohistochemical profiles are so far not very successful in spite of this biochemical difference [5, 6, 10, 19, 38]. Because of the lack of reliable routine histological staining that discriminates these molecular species of tau, combination of biochemical analyses and tau immunostaining is considered the current standard to delineate tau pathology.
Initial observations on these deposits, now known to contain tau protein, were based on silver staining methods. These methods are still widely used for diagnosis of these tauopathies and Alzheimer’s disease (AD) [1, 2, 7, 9, 12, 14, 15, 22, 36]. Further modifications of silver staining methods have been reported [3, 4, 17, 27] that claim an improved sensitivity with lower background and easier standardization of the procedure. Because the Gallyas method (GAL) [12] and its modification [4] are highly successful in visualizing innumerable lesions, it may appear that the differences between silver staining methods are based on their difference in sensitivity. Indeed, various silver staining methods have been demonstrated to have a different sensitivity in detecting AD-related deposits [8, 11, 18, 23, 33, 34, 35, 37].
In our previous study [32], we found that tau-positive lesions in corticobasal degeneration (CBD)/progressive supranuclear palsy (PSP) were positive for GAL but negative for the Campbell-Switzer method (CS) [7, 25], another sensitive silver staining method that labels neurofibrillary tangles of AD (NFTs). Because both GAL and CS label equivalent number of NFTs, this discrepancy between CS and GAL observed in CBD/PSP may represent a feature unique to CBD/PSP. This implies that differences in silver staining methods are related not only to their sensitivities but also to the characteristics of each tau deposit. This prompted us to examine argyrophilic features of another type of tau-positive inclusions, Pick bodies (PBs), that contain predominantly 3R tau. Although little is known about how these argyrophilic properties are formed [13, 16], “argyrophilia” is now found to be dependent not only on the sensitivity of each staining procedure but also on the disease process, and, therefore, is of potential importance in histological distinction of tauopathies. Moreover, this difference in argyrophilic property may possibly represent a different architecture or molecular composition of the deposits.
Materials and methods
Four cases of PB disease (PBD) and four cases of AD were enrolled in this study. Pathological diagnosis of AD was based on the published criteria [21]. Demographic data on these cases are shown in Table 1. Brains were fixed in formalin and embedded in paraffin. Serial hippocampal sections were stained either with GAL [4, 12] or CS [3, 7] and the corresponding argyrophilic structures were compared. Mirror section pairs (4 µm thick) from the hippocampus were subjected to subsequent studies to identify possible relation between argyrophilia and tau-like immunoreactivity, as reported previously [32]. Pairs of mirror sections were first incubated at 4°C for 2 days with an anti-paired helical filament tau antibody (AT8, 1:10,000, Zwijndrecht, Belgium [20]) and the target epitope was visualized with an anti-mouse IgG conjugated with Alexa 488 (1:500, Molecular Probe, Eugene, OR). Sections were then incubated with thiazin red (TR, 1:30,000, Wako, Tokyo, Japan) for 15 min. After being observed under a confocal microscope (Leica TSC/SP, Heidelberg, Germany), one of the section pair was stained with GAL and the other with CS to compare argyrophilic properties of each AT8- or TR-positive structure. Identification of the same microscopic field on the fluorescence images (AT8 and TR) and on the corresponding silver-stained (GAL and CS) pair-wise images allowed us to compare staining profiles of each structure based on four different properties; AT8 immunoreactivity, affinity to TR, argyrophilia with GAL and that with CS.
Results
On hippocampal sections from AD brains, CS visualized NFTs and neuropil threads (NTs) as well as innumerable senile plaques (SPs) (Fig. 1A). On the neighboring section, GAL also visualized NTFs to an equivalent extent and a larger number of NTs (Fig. 1B), while SPs stained with GAL were limited to those with neuritic reactions. On hippocampal sections from PBD, CS clearly visualized PBs (Fig. 1C, E). In contrast, argyrophilia by GAL (Fig. 1D, F) was nearly absent or, if detectable, very weak (asterisks in Fig. 1D).
This contrast was further confirmed on mirror section pairs. Fluorolabeling of a mirror section pair from AD brains with AT8 and TR visualized NFTs and NTs (Fig. 2A, a) that were clearly stained with TR (red) or both TR and AT8 (yellow, Fig. 2A, a, arrowhead), dependent on their evolutionary stage [29]. One of the section pair was subsequently stained with CS (Fig. 2B, C), and the other with GAL (Fig. 2b, c). Each of the CS-positive structures was identifiable on the corresponding mirror section stained with GAL, and vice versa. These structures positive for both CS and GAL (asterisks and arrowheads in Fig. 2B, b, C, c) were also positive for TR or for both TR and AT8 (asterisks and arrowheads in Fig. 2A, a). Another section pair from PBD brains, initially fluorolabeled (Fig. 3A, a) and subsequently silver-stained either with CS (Fig. 3B, C) or GAL (Fig. 3b, c), demonstrated that each of AT8-positive PBs (asterisks and arrowheads in Fig. 3A, a) was stained with CS (Fig. 3B, C, asterisk and arrowhead). GAL, however, failed to label these PBs (Fig. 3b, c). Affinity of TR to these PBs was less evident (Fig. 3A, a) compared with that of NFTs (Fig. 2A, a).
Discussion
A number of methods of silver staining have been developed to delineate pathological lesions related to neurodegeneration [1, 2, 7, 9, 12, 14, 15, 22, 36]. Although some of them are highly useful in diagnosis and research, their utility is based merely on empirical relevance because little is known about the mechanism of how argyrophilic properties are engendered [13, 16, 17, 25]. For AD-related lesions, the number (quantity) of visualized lesions is dependent on the silver staining method used [8, 11, 18, 23, 33, 34, 35, 37]. This gives an impression that the sensitivity for visualizing AD-related lesions is dependent on the silver staining method. Our previous study [32], however, demonstrated that tau-positive lesions in CBD/PSP lacked argyrophilia when they were stained with CS, while they were clearly visualized with GAL. This contrast indicates that each staining method exhibits argyrophilia in disease-dependent manner. In other words, possible difference between silver staining methods is related not only to their sensitivity to detect lesions (quantitative difference) but also to their ability to distinguish lesions in disease-dependent manner (qualitative difference). In the present study, we expanded this approach to PBD, and found that the argyrophilia of PBs was detectable with CS but not with GAL. This staining profile was absolutely complimentary to that observed for tau-positive-lesions in CBD/PSP, which exhibit argyrophilia with GAL but not with CS. Although we have no direct explanation for this empirical distinction, one hypothesis is that argyrophilia with CS is related to tau deposits composed of the 3R species, as we observed in PBD, whereas that with GAL is linked to tau deposits mainly composed of the 4R counterpart, as reported in PSP/CBD [32]. NFTs of Alzheimer type, containing both the 3R and 4R species, exhibit argyrophilia with either CS or GAL (Fig. 4).
Despite this sharp contrast, the staining procedures for GAL and CS are quite similar. Alkaline silver iodide is used after pretreatment with lantanium nitrate for GAL [4], while pyridine-silver is the initial step for CS [7]. Because subsequent visualization of silver particles is essentially the same for GAL and CS, this difference of initial silver reagents (alkaline silver iodide versus pyridine-silver) is one of the major factors responsible for this contrast. However, we do not yet know whether this distinction is based directly on the difference in tau isoforms or related to more complex composition after tau deposition. Another difference between PBs and NFTs depends on their affinity to TR, a fluorochrome that labels fibrillary structures such as NFTs [30] or Lewy bodies [24]. This difference possibly represents a different density of fibrillary structures or qualitative difference in fibrillary composition, as demonstrated previously [29, 30]. The lack of GAL staining, with abundant CS staining, in PBs may be related to this difference. A mixture of 3R and 4R tau, as seen in NFTs, may lead to a more solid organization of fibrils recognized as NFTs [29], also identified clearly with TR. In contrast, deposition of 3R tau not accompanied by its 4R counterpart is organized into different, probably less fibrillary, structures that escape detection with TR or GAL. Our previous study demonstrated that PBs, composed predominantly of the 3R isoform of tau, are preferentially stained with Bodian method (BOD) but not with GAL [31]. Conversely, tau-positive structures in CBD are scarcely argyrophilic with BOD [28]. These data are compatible with the hypothesis that tau deposits, composed of 3R tau, exhibit selective argyrophilia with BOD and CS.
Through these studies, we became aware that each method of silver staining exhibits preferential affinity to tau-positive deposits in an isoform-dependent manner (Fig. 4). Although this correlation is empirical at present, and molecular mechanism to explain how argyrophilic properties specific for disease or tau isoform are engendered still remains to be elucidated, awareness of these differences will help in clearly recognizing and diagnosing specific pathological cascades, which are probably distinct from each other.
References
Bodian D (1936) A new method for staining nerve fibers and nerve endings in mounted paraffin sections. Anat Res 65:89
Bolle L, Maurer B, Janzer RC (1992) A modified Hortega-Globus stain is superior to Bielschowsky and Bodian stains for demonstrating neuritic plaques. Biotech Histochem 67:82–87
Braak E, Braak H (1999) Silver staining method for demonstrating Lewy bodies in Parkinson’s disease and argyrophilic oligodendrocytes in multiple system atrophy. J Neurosci Methods 87:111–115
Braak H, Braak E, Ohm TG, Bohl J (1988) Silver impregnation of Alzheimer’s neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol 63:197–200
Buée-Scherrer V, Hof PR, Buée L, Leveugle B, Vermersch P, Perl DP, Olanow CW, Delacourte A (1996) Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick’s disease. Acta Neuropathol 91:351–359
Bussière T, Hof PR, Mailliot C, Brown CD, Caillet-Boudin M-L, Perl DP, Buée L, Delacourte A (1999) Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration. Acta Neuropathol 97:221–230
Campbell SK, Switzer RC, Martin TL (1987) Alzheimer’s plaques and tangles: a controlled and enhanced silver staining method. Soc Neurosci Abstr 13:67
Connolly AAP, Anderton BA, Esiri MM (1987) A comparative study of a silver stain and monoclonal antibody reactions on Alzheimer’s neurofibrillary tangles. J Neurol Neurosurg Psychiatry 50:1221–1224
Cross RB (1982) Demonstration of neurofibrillary tangles in paraffin sections: a quick and simple method using a modification of Palmgren’s method. Med Lab Sci 39:67–69
De Silva R, Lashley T, Gibb G, Hanger D, Hope A, Reid A, Bandopadhyay R, Utton M, Strand C, Jowett T, Khan N, Anderton B, Wood N, Holton J, Revesz T, Lee A (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol 29:288–302
Duyckaerts C, Brion JP, Hauw JJ, Flament-Durand J (1987) Quantitative assessment of the density of neurofibrillary tangles and senile plaques in senile dementia of the Alzheimer type. Comparison of immunocytochemistry with a specific antibody and Bodian’s protargol method. Acta Neuropathol (Berl) 73:167–170
Gallyas F (1971) Silver staining of Alzheimer’s neurofibrillary changes by means of physical development. Acta Morphol Acad Scient Hung 19:1–8
Gambetti P, Autilio-Gambetti L, Papasozomenos SC (1981) Bodian’s silver method stains neurofilament polypeptides. Science 213:1521–1522
Hicks SP (1946) A rapid pyridine silver stain for nervous tissue and reticular fibers. J Lab Clin Med 31:1375–1377
Hirano A, Zimmerman HM (1962) Silver impregnation of nerve cells and fibers in celloidin sections. A simple impregnation technique. Arch Neurol 6:114–122
Iqbal K, Braak E, Braak H, Zaidi T, Grundke-Iqbal I (1991) A silver impregnation method for labeling both Alzheimer paired helical filaments and their polypeptides separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Neurobiol Aging 12:357–361
Kondoh H, Matsushita M, Kosaka K, Miyazaki N (1993) Staining senile plaques using Bodian’s method modified with methenamine. Biotech Histochem 68:113–116
Lamy C, Duyckaerts C, Delaère P, Payan C, Fermanian J, Poulain V, Hauw JJ (1989) Comparison of seven staining methods for senile plaques and neurofibrillary tangles in a prospective series of 15 elderly patients. Neuropathol Appl Neurobiol 15:563–578
Mailliot C, Sergeant N, Bussière T, Caillet-Boudin M-L, Delacourte A, Buée L (1998) Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett 433:201–204
Mercken M, Vandermeern M, Lübke U, Six J, Boons J, Van de Voorde A, Martin J-J, Gheuens J (1992) Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 84:265–272
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Hughes JP, Belle G van, Berg L (1991) The consortium to establish a registry for Alzheimer’s disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 42:479–486
Reusche E (1991) Silver staining of senile plaques and neurofibrillary tangles in paraffin sections. A simple and effective method. Pathol Res Pract 187:1045–1049
Rosenwald A, Reusche E, Ogomori K, Teichert H-M (1993) Comparison of silver staining and immunohistology for the detection of neurofibrillary tangles and extracellular cerebral amyloid in paraffin sections. Acta Neuropathol 86:182–186
Sakamoto M, Uchihara T, Hayashi M, Nakamura A, Kikuchi E, Mizutani T, Mizusawa H, Hirai S (2002) Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red. Exp Neurol 177:88–94
Switzer RC 3rd (1993) Silver staining methods: their role in detecting neurotoxicity. Ann N Y Acad Sci 679:341–348
Tolnay M, Probst A (1999) Tau protein pathology in Alzheimer’s disease and related disorders. Neuropathol Appl Neurobiol 25:171–187
Uchihara T, Kondo H, Ikeda K, Kosaka K (1995) Alzheimer-type pathology in melanin-bleached sections of substantia nigra. J Neurol 252:485–489
Uchihara T, Mizusawa H, Tsuchiya K, Kondo H, Oda T, Ikeda K (1998) Discrepancy between tau immunoreactivity and argyrophilia by the Bodian method in neocortical neurons of corticobasal degeneration. Acta Neuropathol 96:553–557
Uchihara T, Nakamura A, Yamazaki M, Mori O (2001) Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol 101:535–539
Uchihara T, Nakamura A, Yamazaki M, Mori O, Ikeda K, Tsuchiya K (2001) Different conformation of neuronal tau deposits distinguished by double immunofluorescence with AT8 and thiazin red combined with Gallyas method. Acta Neuropathol 102:462–466
Uchihara T, Ikeda K, Tsuchiya K (2003) Pick body disease and Pick syndrome. Neuropathology 23:318–326
Uchihara T, Shibuya K, Nakamura A, Yagishita S (in press) Silver stains distinguish tau-positive structures in corticobasal degeneration/progressive supranuclear palsy and in Alzheimer’s disease: Comparison between Gallyas and Campbell-Switzer methods. Acta Neuropathol
Vallet PG, Guntern R, Hof PR, Golaz J, Delacourte A, Robakis NK, Bouras C (1992) A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer’s disease. Acta Neuropathol 83:170–178
Wilcock GK, Matthews SM, Moss T (1990) Comparison of three silver stains for demonstrating neurofibrillary tangles and neuritic plaques in brain tissue stored for long periods. Acta Neuropathol 79:566–568
Wisniewski HM, Wen GY, Kim KS (1989) Comparison of four staining methods on the detection of neuritic plaques. Acta Neuropathol 78:22–27
Yamaguchi H, Haga C, Hirai S, Nakazato Y, Kosaka K (1990) Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brain by a new methenamine silver stain. Acta Neuropathol 79:569–572
Yamamoto T, Hirano A (1986) A comparative study of modified Bielshowsky, Bodian and Thioflavin S stains on Alzheimer’s neurofibrillary tangles. Neuropathol Appl Neurobiol 12:3–9
Yen SH, Horoupian DS, Terry RD (1983) Immunocytochemical comparison of neurofibrillary tangles in senile dementia of Alzheimer type, progressive supranuclear palsy, and postencephalitic Parkinsonism. Ann Neurol 13:172–175
Acknowledgements
This work was supported in part by grants from the Ministry of Health and Welfare, Japan (Longevity Science H-14–005) and the Ministry of Education, Culture, Sports, Science and Technology (grant in aid for scientific research B15300118) to T.U.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uchihara, T., Tsuchiya, K., Nakamura, A. et al. Silver staining profiles distinguish Pick bodies from neurofibrillary tangles of Alzheimer type: comparison between Gallyas and Campbell-Switzer methods. Acta Neuropathol 109, 483–489 (2005). https://doi.org/10.1007/s00401-005-0988-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-005-0988-6